History of the clinical use of umbilical cord blood hematopoietic cells

References

• Auerbach AD, Liu O, Ghosh R, et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990; 30: 682–7
   Google Scholar
• Broxmeyer HE, Gordon GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–32
   PubMed Web of Science ®Google Scholar
• Gluckman E, Devergie A, Schaison G, et al. Bone marrow transplantation in Fanconi anemia. Br J Haematol 1980; 45: 557–64
   PubMed Web of Science ®Google Scholar
• Berger R, Bernheim A, Gluckman E, et al. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anemia patients. Br J Haematol 1980; 45: 565–8
   PubMed Web of Science ®Google Scholar
• Gluckman E, Devergie A, Dutreix J. Radio sensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431–40
   PubMed Web of Science ®Google Scholar
• Linch DC, Knott LJ, Rodeck CH, Huehns CH. Studies of circulating hematopoietic progenitor cells in human fetal blood. Blood 1982; 59: 976–82
   Google Scholar
• Hann IM, Bodger MP, Hoffbrand AV. Development of pluripotent hematopoietic progenitor cells in human fetuses. Blood 1983; 62: 118–23
   Google Scholar
• Forestier F, Daffos F, Catherine N, et al. Developmental hematopoiesis in normal human fetal blood. Blood 1991; 77: 2360–3
   PubMed Web of Science ®Google Scholar
• Harrison MR, Crombleholme TM, Tarantal AF, et al. In utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 1989; ii: 1425–7
   Google Scholar
• Gale RP. Fetal liver transplantation in man in fetal liver transplantation. Current concepts and future directions. Excerpta Medica International Congress Series 514, G Lucarelli, TM Fliedner, RP Gale, 1980; 268–275
   Google Scholar
• Broxmeyer HE, Gluckman E, Auerbach A, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J cell Cloning 1990; 8: 76–91
   PubMedGoogle Scholar
• Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109–13
   PubMed Web of Science ®Google Scholar
• Burgio GR, Gluckman E, Locatelli F. Ethical reappraisal of 15 years of cord blood transplantation. Lancet 2003; 361: 250–2
   PubMed Web of Science ®Google Scholar
• Gluckman E, O'Reilly R, Wagner J, Rubinstein P. Patents versus transplants. Nature 1996; 382: 108
   Google Scholar
• Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–8
   PubMed Web of Science ®Google Scholar
• Wagner JE, Kernan NA, Steinbuch M, et al. Allogeneic sibling cord blood transplantation in forty four children with malignant and non malignant disease. Lancet 1995; 346: 214–19
   PubMed Web of Science ®Google Scholar
• Linch DC, Brent L. Can cord blood be used?. Nature 1989; 340: 676
   Google Scholar
• Nathan DG. The beneficence of neonatal hematopoiesis. N Engl J Med 1982; 321: 1190
   Google Scholar
• Caux C, Favre C, Saeland S, et al. Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with IL-3: characterization of CD34−, HLA-DR+ cells. Blood 1989; 74: 1287–94
   PubMed Web of Science ®Google Scholar
• Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD34+ cells in the human neonate. J Immunol 1990; 145: 102–8
   PubMed Web of Science ®Google Scholar
• Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitors cells from human umbilical cord blood. Blood 1994; 83: 2410–17
   PubMed Web of Science ®Google Scholar
• Vaziri H, Dragowska W, Allsop RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857–60
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Wandycz AM, Akashi K, et al. The aging of hematopoietic stem cells. Nature Med 1996; 2: 1011–16
   PubMed Web of Science ®Google Scholar
• Petit T, Dommergues M, Socié G, et al. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele specific PCR amplification. Br J Haematol 1997; 98: 767–71
   PubMed Web of Science ®Google Scholar
• Griffiths-Chu S, Patterson JAK, Berger CL, et al. Characterization of immature T cell subpopulations in neonatal blood. Blood 1984; 64: 296–300
   Google Scholar
• Durandy A, Thuillier L, Forveille M, Fischer A. Phenotypic and functional characteristics of human newborns B lymphocytes. J Immunol 1990; 144: 60–5
   PubMed Web of Science ®Google Scholar
• Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1006–10
   Google Scholar
• McDouall RM, Suitters AJ, Smith H, et al. Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 1994; 95: 519–24
   Google Scholar
• Madrigal JA, Cohen SBA, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft versus host disease? It takes more than two to tango. Human Immunol 1997; 56: 1–5
   PubMed Web of Science ®Google Scholar
• De La Selle V, Gluckman E, Bruley-Rosset M. Newborn blood can engraft adult mice without inducing graft versus host disease across non H-2 antigens. Blood 1996; 87: 3977–83
   PubMed Web of Science ®Google Scholar
• De La Selle V, Gluckman E, Bruley-Rosset M. Graft versus host disease and graft versus leukemia effect in mice grafted with newborn blood. Blood 1998; 15: 3968–75
   Google Scholar
• Rocha V, Wagner JE, Sobocinski K, et al. Comparison of graft-versus-host disease in children transplanted with HLA identical sibling umbilical cord blood versus HLA identical sibling bone marrow transplant. N Engl J Med 2000; 342: 1846–54
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers E, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–71
   PubMed Web of Science ®Google Scholar
• Rocha, V, Labopin, M, Sanz, G, , et al. The Acute Leukemia Working Party of European Blood and Marrow Transplant group and Eurocord-Netcord registry. Comparison of outcomes after unrelated umbilical cord versus unrelated bone marrow transplants in adults with acute leukemia. N Engl J Med 2004;351:12–21.
   Google Scholar
• Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–61
   PubMed Web of Science ®Google Scholar
• Garderet L, Dulphy N, Douay C, et al. The umbilical cord blood αβ T cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998; 91: 340–6
   PubMed Web of Science ®Google Scholar
• Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458–64
   PubMed Web of Science ®Google Scholar
• Niehues T, Rocha V, Filipovich AH, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001; 114: 42–8
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Rosenfield RD, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993; 81: 1679–90
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–22
   PubMed Web of Science ®Google Scholar
• Wernet PW. The International Netcord Foundation in Cord Blood. Biology, Immunology, Banking and Clinical Transplantation. AABB Press, Bethesda, MD 2004
   Google Scholar
• Gluckman E, Rocha V, Boyer Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373–81
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999; 93: 3662–7
   PubMed Web of Science ®Google Scholar
• Michel G, Rocha V, Chevret S, et al. For the Eurocord Group. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord group analysis. Blood 2003; 102: 1–8
   Google Scholar
• Cairo MS, Wagner JE. Placental and/or umbilical cord blood an alternative source of haemopoietic stem cells for transplantation. Blood 1997; 90: 4665–78
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Laughlin M, Graham L, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–66
   PubMed Web of Science ®Google Scholar
• Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA matched and HLA mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft versus host disease. Blood 1996; 88: 795–802
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–77
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–22
   PubMed Web of Science ®Google Scholar
• Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001; 98: 2332–8
   PubMed Web of Science ®Google Scholar
• Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003; 101: 4711–13
   PubMed Web of Science ®Google Scholar
• Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489–91
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Arcese W, et al. On behalf of Eurocord group. Factors associated with outcome of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397–407
   PubMed Web of Science ®Google Scholar
• Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–18
   PubMed Web of Science ®Google Scholar
• Frassoni F, Podestà M, Maccario R, et al. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 2003; 102: 1138–41
   Google Scholar
• Migliaccio AM, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–22
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915–9
   PubMed Web of Science ®Google Scholar